A Dual SIRT6/Classical HDAC Inhibitor with Integrated Antiproliferative, Antimigratory, and Pharmacokinetic Advantages Against Pancreatic Cancer

Abstract Pancreatic cancer (PC) is highly malignant, with a poor prognosis and high metastatic potential. Given the synergy between sirtuin 6 (SIRT6) and classical histone deacetylase (HDAC) in regulating epithelial−mesenchymal transition (EMT), dual-target inhibitors may offer improved antimetastatic therapy. The lead compound 11e suffers from poor metabolic stability, weak antiproliferative activity, and insufficient antimigratory capacity. Through pharmacophore merging and structural optimization, we obtained S20, which potently inhibits SIRT6 (IC50 = 3.903 μM) and classical HDACs (IC50 = 0.217 μM). In vitro, S20 was superior to 11e in antiproliferative activity and showed stronger antimigratory activity than SAHA, 11e, or their combination. Mechanistically, S20 modulated EMT-associated marker expression, increasing E-cadherin while decreasing N-cadherin, vimentin, and ZEB1. Its intravenous half-life (4.11 h) was 14.7-fold longer than 11e (0.28 h). In vivo, S20 dose-dependently suppressed liver metastasis with favorable safety. In summary, S20 exhibits comprehensive advantages in antiproliferative, antimigratory, and metabolic stability, providing a new strategy for antimetastatic drug development.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2026-11-12
DOI
https://doi.org/10.1021/acs.jmedchem.6c02028
Primary Topic
Histone Deacetylase Inhibitors Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Dual SIRT6/Classical HDAC Inhibitor with Integrated Antiproliferative, Antimigratory, and Pharmacokinetic Advantages Against Pancreatic Cancer

Mingzhu Zhao, Kui Cheng, Cui Yunxia, En yu Liang et al.
Journal of Medicinal Chemistry
Histone Deacetylase Inhibitors Research
article

A Dual SIRT6/Classical HDAC Inhibitor with Integrated Antiproliferative, Antimigratory, and Pharmacokinetic Advantages Against Pancreatic Cancer

Mingzhu Zhao, Kui Cheng, Cui Yunxia, En yu Liang, Jian Zhang, Yan Zheng, Lirong Zhang, Bicong Cong, Leisheng Xu, Shiying Zhu, Qiao Li
article en

Abstract

Abstract Pancreatic cancer (PC) is highly malignant, with a poor prognosis and high metastatic potential. Given the synergy between sirtuin 6 (SIRT6) and classical histone deacetylase (HDAC) in regulating epithelial−mesenchymal transition (EMT), dual-target inhibitors may offer improved antimetastatic therapy. The lead compound 11e suffers from poor metabolic stability, weak antiproliferative activity, and insufficient antimigratory capacity. Through pharmacophore merging and structural optimization, we obtained S20, which potently inhibits SIRT6 (IC50 = 3.903 μM) and classical HDACs (IC50 = 0.217 μM). In vitro, S20 was superior to 11e in antiproliferative activity and showed stronger antimigratory activity than SAHA, 11e, or their combination. Mechanistically, S20 modulated EMT-associated marker expression, increasing E-cadherin while decreasing N-cadherin, vimentin, and ZEB1. Its intravenous half-life (4.11 h) was 14.7-fold longer than 11e (0.28 h). In vivo, S20 dose-dependently suppressed liver metastasis with favorable safety. In summary, S20 exhibits comprehensive advantages in antiproliferative, antimigratory, and metabolic stability, providing a new strategy for antimetastatic drug development.

Journal of Medicinal Chemistry
Shanghai Jiao Tong University (CN), Southern Medical University (CN)
Innovative Research Team of High-level Local University in Shanghai, National Natural Science Foundation of China, National Key Research and Development Program of China
Good health and well-being
Histone Deacetylase Inhibitors Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon